Bridgeway Capital Management’s Core Molding Technologies CMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.43M Buy
108,368
+884
+0.8% +$17.4K 0.05% 475
2025
Q4
$2.16M Buy
107,484
+967
+0.9% +$18.5K 0.05% 508
2025
Q3
$2.19M Buy
106,517
+7,643
+8% +$142K 0.05% 524
2025
Q2
$1.64M Buy
98,874
+4,012
+4% +$63.1K 0.04% 568
2025
Q1
$1.44M Sell
94,862
-11,812
-11% -$169K 0.04% 571
2024
Q4
$1.76M Buy
106,674
+1,292
+1% +$21.2K 0.04% 551
2024
Q3
$1.81M Buy
105,382
+7,642
+8% +$133K 0.04% 537
2024
Q2
$1.56M Buy
97,740
+2,340
+2% +$42.8K 0.04% 571
2024
Q1
$1.81M Buy
95,400
+2,287
+2% +$40.9K 0.04% 604
2023
Q4
$1.73M Buy
93,113
+2,688
+3% +$58.7K 0.04% 635
2023
Q3
$2.58M Sell
90,425
-15,496
-15% -$390K 0.06% 461
2023
Q2
$2.41M Sell
105,921
-11,992
-10% -$233K 0.06% 490
2023
Q1
$2.12M Sell
117,913
-8,755
-7% -$137K 0.06% 507
2022
Q4
$1.65M Hold
126,668
0.04% 610
2022
Q3
$1.26M Buy
126,668
+4,564
+4% +$50.7K 0.03% 680
2022
Q2
$1.12M Hold
122,104
0.03% 699
2022
Q1
$1.31M Hold
122,104
0.03% 713
2021
Q4
$1.04M Buy
122,104
+7,507
+7% +$75.1K 0.02% 784
2021
Q3
$1.32M Buy
114,597
+1,697
+2% +$23.9K 0.03% 750
2021
Q2
$1.74M Sell
112,900
-15,300
-12% -$198K 0.03% 674
2021
Q1
$1.5M Buy
128,200
+20,800
+19% +$261K 0.03% 720
2020
Q4
$1.51M Buy
107,400
+5,300
+5% +$56.7K 0.03% 621
2020
Q3
$905K Buy
102,100
+37,700
+59% +$234K 0.02% 713
2020
Q2
$265K Buy
64,400
+10,200
+19% +$32.8K 0.01% 1075
2020
Q1
$83K Hold
54,200
﹤0.01% 1192
2019
Q4
$176K Sell
54,200
-16,400
-23% -$72.9K ﹤0.01% 1210
2019
Q3
$453K Hold
70,600
0.01% 993
2019
Q2
$527K Hold
70,600
0.01% 960
2019
Q1
$521K Hold
70,600
0.01% 1012
2018
Q4
$502K Sell
70,600
-46,900
-40% -$338K 0.01% 1002
2018
Q3
$784K Buy
117,500
+35,000
+42% +$377K 0.01% 994
2018
Q2
$1.18M Sell
82,500
-3,000
-4% -$46.2K 0.01% 816
2018
Q1
$1.52M Sell
85,500
-3,100
-3% -$60.5K 0.02% 685
2017
Q4
$1.92M Sell
88,600
-300
-0.3% -$6.62K 0.02% 613
2017
Q3
$1.95M Hold
88,900
0.02% 608
2017
Q2
$1.92M Buy
88,900
+100
+0.1% +$1.99K 0.02% 597
2017
Q1
$1.58M Buy
88,800
+300
+0.3% +$4.81K 0.02% 645
2016
Q4
$1.51M Hold
88,500
0.02% 657
2016
Q3
$1.5M Hold
88,500
0.02% 637
2016
Q2
$1.21M Sell
88,500
-95,000
-52% -$1.17M 0.02% 711
2016
Q1
$2.29M Hold
183,500
0.04% 466
2015
Q4
$2.35M Buy
183,500
+3,000
+2% +$47.8K 0.04% 451
2015
Q3
$3.33M Sell
180,500
-13,625
-7% -$270K 0.07% 302
2015
Q2
$4.43M Buy
194,125
+86,300
+80% +$1.99M 0.09% 251
2015
Q1
$1.85M Buy
107,825
+8,800
+9% +$129K 0.04% 546
2014
Q4
$1.38M Hold
99,025
0.03% 663
2014
Q3
$1.4M Sell
99,025
-12,700
-11% -$173K 0.04% 620
2014
Q2
$1.45M Hold
111,725
0.04% 621
2014
Q1
$1.42M Buy
111,725
+31,300
+39% +$420K 0.04% 620
2013
Q4
$1.1M Hold
80,425
0.03% 705
2013
Q3
$770K Buy
80,425
+700
+0.9% +$6.46K 0.03% 836
2013
Q2
$711K Buy
+79,725
New +$710K 0.03% 781

Other funds holding CMT

Bridgeway Capital Management's CMT Position: Q1 2026 in Review

Bridgeway Capital Management increased its Core Molding Technologies (CMT) stake by 0.82% in Q1 2026, buying an estimated $17.4K and bringing the position to 108,368 shares worth $2.43M. The position accounts for 0.05% of the portfolio, ranked #475.

Bridgeway Capital Management first reported a position in CMT in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.43M in Q2 2015. 97 funds tracked by Wall St. Rank hold CMT as of Q1 2026.

  • Bridgeway Capital Management held 108,368 shares of Core Molding Technologies worth $2.43M as of Q1 2026.
  • Bridgeway Capital Management bought 884 Core Molding Technologies shares in Q1 2026, an estimated $17.4K.
  • Core Molding Technologies made up 0.05% of Bridgeway Capital Management's portfolio in Q1 2026, its #475 holding.
  • Bridgeway Capital Management first reported a position in Core Molding Technologies in Q2 2013 and has held it in 52 quarters since.
  • Bridgeway Capital Management's Core Molding Technologies position peaked at $4.43M in Q2 2015.
  • 97 funds tracked by Wall St. Rank held Core Molding Technologies as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.